Focus on Melanoma Meeting 2024
Friday 18th October 2024
Organised by: A group of Dermatology Consultants
Location: The Royal College of Physicians, London
| Friday, 18th October 2024 | 9:00 am – 5:10 pm |
Join us for the Focus on Melanoma 2024 CME accredited meeting.
This year’s Focus on Melanoma has been approved by the Federation of the Royal Colleges of Physicians of the United Kingdom for 6 category 1 (external) CPD credit(s). The British Association of Plastic, Reconstructive and Aesthetic Surgeons have awarded up to 6 CME credits. The Royal College of Surgeons of England has awarded up to 6.5 CPD points.
If you would like to be invoiced for your registration fee, please email jenn@melanomafocus.org
Focus on Melanoma 2024 Programme
| 09:00 – 09:55 | BMS SPONSORED SYMPOSIUM: New Era of Dual I-O: Navigating Conundrums in the Treatment and Care of Advanced Melanoma Chair: Dr Heather Shaw, Consultant Medical Oncologist, Mount Vernon Cancer Centre and University College London Hospital -Professor Paul Nathan, Consultant Medical Oncologist, Mount Vernon Cancer Centre -Dr Toby Talbot, Consultant Medical Oncologist, Royal Cornwall Hospital |
| 10:00 – 10:05 | Welcome/Introductions Dr Mark Harries, Consultant Medical Oncologist, Guy’s and St Thomas’ NHS Foundation Trust and Chairman of Melanoma Focus |
| 10:05 – 10:15 | Melanoma Focus: Achievements and Plans Dr Mark Harries and Susanna Daniels |
| 10:15 – 11:10 | Session 1: New Developments and Clinical Trials Chair: Dr Amaya Viros, CRUK Advanced Academic Clinician Scientist Cancer Research UK Manchester Institute & Honorary Consultant Dermatologist Salford Royal NHS Trust |
| 10:15 – 10:45 | Neo-adjuvant and Other Systemic Treatment Advances Professor Paul Nathan, Consultant Medical Oncologist, Mount Vernon Cancer Centre |
| 10:45 – 10:55 | An Update on Melanoma Epidemiology from National Cancer Registry Data Dr Zoe Venables, Consultant Dermatologist Norfolk & Norwich University Hospitals NHS Foundation Trust and Dermatology Clinical Lead NDRS |
| 10:55 – 11:05 | UK Skin Cancer Clinical Trials Group update Dr Brent O’Carrigan, Consultant Medical Oncologist, Cambridge University Hospitals NHS Trust |
| 11:05 – 11:10 | Q&A |
| 11:10 – 11:35 | Break |
| 11:35 – 12:50 | Session 2: Artificial Intelligence Chairs: Professor Charlotte Proby, Professor of Dermatology and Honorary Consultant Dermatologist, Ninewells Hospital & Medical School and Dr Rubeta Matin, Consultant Dermatologist and Honorary Senior Clinical Lecturer, Oxford University Hospitals NHS Foundation Trust |
| 11:35 – 11:55 | AI and Melanoma Diagnostics – where are we now? Dr Rubeta Matin, Consultant Dermatologist and Honorary Senior Clinical Lecturer, Oxford University Hospitals NHS Foundation Trust |
| 11:55 – 12:15 | The Potential role of AI Supporting Teledermatology Services The UK experience – pros and cons Dr Carolyn Charman, Consultant Dermatologist, Royal Devon University Healthcare, British Association of Dermatologists Clinical Vice President |
| 12:15 – 12:35 | AI Skin Cancer Consortium Professor Colin Fleming, Consultant Dermatologist and Director of Innovation, NHS Tayside |
| 12:35 – 12:50 | Q&A |
| 12:50 – 13:30 | Session 3: Surgical Dilemmas Chair: Professor Marc Moncrieff, Consultant Plastic Reconstructive Surgeon, Norfolk & Norwich University Hospitals NHS Foundation Trust |
| 13:00 – 13:25 | Is There still a Role for CLND for Micrometastatic Melanoma? Mr Ewan Wilson, Consultant Plastic Reconstructive Surgeon, North Bristol NHS Trust |
| 13:25 – 13:30 | Q&A |
| 13:30 – 14:30 | Lunch |
| 14:30 – 15:15 | The Professor Martin Gore CBE Memorial Lecture Introduction – Dr Mark Harries, Consultant Medical Oncologist, Guy’s and St Thomas’ NHS Foundation Trust and Chairman of Melanoma Focus
From Bench to Bedside and Back: What we Have Learned and What we are Still Missing
Professor Dirk Schadendorf, Director and Chair, Department of Dermatology & Director, Comprehensive Cancer Center, University Hospital Essen, Germany |
| 15:15 – 16:10 | Session 4: Immunotherapy Toxicities Chair: Professor Catherine Harwood, Professor of Dermatology, Barts’ Health NHS Trust |
| 15:15 – 15:40 | Guidelines to Manage Dermatology IO Toxicity Dr Andy Muinonen-Martin, Consultant Dermatologist, Leeds Teaching Hospitals NHS Foundation Trust |
| 15:40 – 16:00 | Identifying determinants of response and toxicities to immune checkpoint blockade in melanoma Professor Ben Fairfax, Professor of Cancer Immunogenetics, Wellcome Intermediate Clinical Fellow and Honorary Consultant Medical Oncologist, University of Oxford |
| 16:00 – 16:10 | Q&A |
| 16:10 – 17:10 | Session 5: MDT: Challenging Toxicities Chair: Dr Kate Young, Consultant Medical Oncologist, The Royal Marsden Hospital NHS Foundation Trust Panel: |
| 17:10 | Close |
| 17:10 – 19:00 | Drinks Reception and Networking |